Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Safety Profile, Feasibility and Early Clinical Outcome of Cotransplantation of Olfactory Mucosa and Bone Marrow Stem Cells in Chronic Spinal Cord Injury Patients

Safety Profile, Feasibility and Early Clinical Outcome of Cotransplantation of Olfactory Mucosa and Bone Marrow Stem Cells in Chronic Spinal Cord Injury Patients

Asian Spine J, 2014 · DOI: 10.4184/asj.2014.8.4.484 · Published: August 1, 2014

Spinal Cord InjuryRegenerative Medicine

Simple Explanation

This study explores the use of tissue engineering, where biological substitutes are developed to regenerate tissues or restore biological functions, specifically for spinal cord injuries. The study involved transplanting bone marrow and olfactory mucosal stem cells into the spinal cord of patients with spinal injuries to assess the safety and early clinical results of this method. The procedure aims to leverage the regenerative properties of stem cells to potentially repair damaged spinal cords and improve neurological function in individuals with paraplegia.

Study Duration
24-month follow-up
Participants
9 dorsal spine injury patients with American Spinal Injury Association (ASIA) Impairment Scale (AIS) A neurological impairment
Evidence Level
Level 4; Prospective case series

Key Findings

  • 1
    The cotransplantation procedure was found to be safe and feasible for patients with thoracic level injuries, as assessed at the 24-month follow-up.
  • 2
    No significant improvement in ASIA scores was observed, indicating no demonstrable efficacy in terms of neurological recovery.
  • 3
    MRI evaluations showed an increase in the length of myelomalacia in seven participants, suggesting potential adverse effects or disease progression.

Research Summary

The study investigates the safety and feasibility of cotransplantation of bone marrow stem cells and autologous olfactory mucosa in chronic spinal cord injury patients with AIS A neurological impairment. The results showed that the procedure was well-tolerated, but no significant neurological improvement was observed, and MRI revealed increased myelomalacia in most patients. The authors conclude that while the procedure is safe and feasible, further large-scale studies are necessary to determine its efficacy in spinal cord regeneration.

Practical Implications

Safety and Feasibility

The study suggests that cotransplantation of bone marrow stem cells and olfactory mucosa is a safe procedure for patients with chronic spinal cord injuries.

Limited Efficacy

The research indicates that the procedure does not provide significant neurological improvement, suggesting that it might not be effective as a standalone treatment.

Need for Further Research

Large-scale randomized controlled trials are needed to validate the efficacy and potential benefits of this cotransplantation method.

Study Limitations

  • 1
    Small sample size
  • 2
    Inability to estimate the exact number of transplanted cells
  • 3
    Absence of a control group

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury